Improving Attention in Individuals With Long COVID-19
Public ClinicalTrials.gov record NCT06503874. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Intensive Attention Training to Treat Brain Fog in Individuals With Long-Covid
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is to find out if the Attention Processing Training program is a potential treatment for brain fog symptoms, reported by people with Long-Covid. Also investigating the feasibility of completing this program virtually.
Study identification
- NCT ID
- NCT06503874
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 58 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 21, 2024
- Primary completion
- Mar 12, 2026
- Completion
- Mar 12, 2026
- Last update posted
- Apr 1, 2026
2024 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Shirley Ryan AbilityLab | Chicago | Illinois | 60611 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Long Covid trials
Other public records listing Long Covid. Sorted by last update posted; newest first. Not a recommendation.
- NCT06847191: NE3107 in Adults With Neurological Symptoms of Long COVID Active, not recruiting
- NCT07770022: Validation of Biomarkers for Long COVID in the LIINC Viral Immunopathogenesis and Persistence Repeat Donor Cohort (VIPER) Recruiting
- NCT06920628: PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Recruiting
- NCT06585254: tVNS in Long COVID-19 Active, not recruiting
- NCT05373043: Long-term COVID and Rehabilitation Recruiting
- NCT06928116: Heat thErapy And mobiLity in COVID-19 Survivors Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06503874, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 1, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06503874 live on ClinicalTrials.gov.